The pivotal molecular mechanisms of luteolin antagonizing COVID-19 may lie in the improvement of vascular circulation through inhibiting the vascular inflammation triggered by NF-κB and TNF-α, and has a n important beneficial effect on improving unusual angiogenesis and vascular leakage during COVID-19 [118,119]. The gene discussed is NFKB1; the disease is COVID-19.